yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q24646379-B6892066-0DCF-47ED-B0DB-FC24077F05CF
Q24646379-B6892066-0DCF-47ED-B0DB-FC24077F05CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24646379-B6892066-0DCF-47ED-B0DB-FC24077F05CF
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers
P2860
Q24646379-B6892066-0DCF-47ED-B0DB-FC24077F05CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24646379-B6892066-0DCF-47ED-B0DB-FC24077F05CF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d3494d6eacfa9a7d092b0b8b40d949c3e75fdad5
P2860
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.